The Company
This finance leader employs over 28,000 individuals across Northern Europe and is known for its strong emphasis on information security due to the sensitive nature of its operations.
Business Challenges
Hypertrophic Cardiomyopathy, also known as HCM, is one of the most common genetic cardiovascular diseases, and it is often misdiagnosed, leading to delays in patient care. This non-profit organization recently partnered with a biological research company to update the diagnosis and treatment guidelines. The updated procedures aim to eliminate these barriers and streamline the diagnostic journey for patients, ensuring timely and accurate diagnosis.
They needed an updated training program that would help them address the challenges they were facing including:
- Slow adoption of new clinical practice guidelines.
- Lack of knowledge about HCM disease pathology.
- Lack of knowledge around the latest science and guidance.
